GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma

The emergence of sorafenib resistance has become a predominant impediment and formidable dilemma in the therapeutic approach for hepatocellular carcinoma (HCC). Although the approval of next-generation drugs as alternatives to sorafenib is a significant development, the concurrent use of inhibitors...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shiwen Ma, Fei Xie, Xiaohu Wen, Yao Mawulikplimi Adzavon, Ruping Zhao, Jinyi Zhao, Han Li, Yanqi Li, Jingtao Liu, Chen Liu, Yang Yi, Pengxiang Zhao, Boqing Wang, Wei Zhao, Xuemei Ma
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-12-01
Edice:	Pharmacological Research
Témata:	GSTA1 Sorafenib Drug resistance Ferroptosis Hepatocellular carcinoma (HCC)
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S1043661824004353
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!